Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION …
{{id}} {{{paragraph}}}
Example: air traffic controller
HIGHLIGHTS OF PRESCRIBING INFORMATION …
HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese HIGHLIGHTS do not include all the INFORMATION needed to use KEVZARA safely andeffectively. See full PRESCRIBING INFORMATION for (sarilumab) injection, for subcutaneous useInitial Approval: 2017 WARNING: RISK OF SERIOUS INFECTIONSSee full PRESCRIBING INFORMATION for complete boxed warning. Serious infections leading to hospitalization or death including bacterial, viral,invasive fungal, and other opportunistic infections have occurred in patientsreceiving KEVZARA. ( ) If a serious infection develops, interrupt KEVZARA until the infection is controlled.( ) Cases of tuberculosis (TB) have been reported. Prior to starting KEVZARA, test forlatent TB; if positive, start treatment for TB. ( ) Closely monitor patients for signs and symptoms of infection during treatment withKEVZARA.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEVZARA® safely and effectively. See full prescribing information for KEVZARA.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: